Crohn's disease and ulcerative colitis are idiopathic, chronic, relapsing, inflammatory conditions that are immunologically mediated. Although their exact etiologies remain uncertain, results from ...

The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...

July 17, 2023 — Chronic inflammatory bowel disease (IBD), such as Crohn's disease and ulcerative colitis, is on the rise worldwide. The benefits of current medications are limited by problematic ...

A new test developed in the UK can accurately predict whether high-risk patients will develop bowel cancer, also known as ...

Daniel Vitt, CEO, Immunic Therapeutics, discusses promising results from the Phase Ib trial of IMU-856 in celiac disease.

“Furthermore, these data strongly encourage us to pursue phase 2 clinical trials in other inflammatory indications including Crohn’s disease.” Ulcerative colitis is a debilitating ...

Eli Lilly has said it plans to file its anti-IL-23p19 antibody mirikizumab for approval as a treatment for Crohn’s disease next ... of mirikizumab for ulcerative colitis (UC) earlier this ...

It is important to biopsy all ulcers and perform histology and microbiology tests ... Italy Diagnosis of intestinal Crohn's disease (CD) is challenging, since its signs/symptoms can be mimicked ...

Ulcerative colitis affects daily life, but proper management can help maintain quality of life. Learn how to cope with this ...

However, the Crohn’s & Colitis Foundation suggests that microscopic colitis may develop due to a combination of factors. This means that it’s possibly an autoimmune disease, but other causes ...

Janus kinase (JAK) inhibitors can quickly and effectively manage ulcerative colitis (UC), especially when more conventional treatments haven’t worked. UC is a type of inflammatory bowel disease ...

Researchers identified that the dominant B cell epitope of Lachnospiraceae flagellins and the utilization of the flagellin ...